EPC26.1.1
The cell line is not validated yet.
SCTCi037-A-1
General
Cell Line |
|
| hPSCreg name | SCTCi037-A-1 |
| Cite as: | SCTCi037-A-1 |
| Alternative name(s) |
EPC26.1.1
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Similar lines |
SCTCi037-A (IPS19-00015) Donor's gene variants: KCNQ2 Donor diseases: developmental and epileptic encephalopathy, 7 SCTCi039-A-1 (NGC22.3.369) Donor's gene variants: KCNQ2 Donor diseases: developmental and epileptic encephalopathy, 7 BCHi046-A-3 (HNDS0069-01#B Pass-Match-Control) Donor diseases: Developmental and Epileptic Encephalopathy 7 SCTCi021-A (IPS17-00027) Donor's gene variants: KCNQ2 Donor diseases: developmental and epileptic encephalopathy, 7 SCTCi022-A (IPS17-00042) Donor's gene variants: KCNQ2 Donor diseases: developmental and epileptic encephalopathy, 7 SCTCi024-A (IPS18-00047) Donor's gene variants: KCNQ2 Donor diseases: developmental and epileptic encephalopathy, 7 SCTCi039-A (IPS19-00092) Donor's gene variants: KCNQ2 Donor diseases: developmental and epileptic encephalopathy, 7 SCTCi023-A (IPS17-00063) Donor's gene variants: KCNQ2 Donor diseases: self-limited familial neonatal epilepsy SCTCi025-A (IPS18-00095) Donor's gene variants: KCNQ2 Donor diseases: self-limited familial neonatal epilepsy |
| Last update | 13th August 2025 |
| User feedback | |
Provider |
|
| Generator | Radboudumc Stem Cell Technology Center (SCTC) |
| Owner | VIB - Center for Molecular Neurology (VIBCMN) |
| Distributors | |
| Derivation country | Belgium |
External Databases |
|
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
|
| Subclone of | |
Donor Information
General Donor Information |
|
| Sex | female |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed.
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA115428386 |
Ethics
Also have a look at the ethics information for the parental line
SCTCi037-A
.
| Is there an MTA available for the cell line? | No |
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | |
| Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? | No |
hIPSC Derivation
General |
|
|
The source cell information can be found in the parental cell line
SCTCi037-A.
|
|
Reprogramming method |
|
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
No |
| Derived under GMP? |
No |
| Available as clinical grade? |
No |
Culture Conditions
| Surface coating | Matrigel/Geltrex |
| Feeder cells |
No |
| Passage method |
Enzyme-free cell dissociation
EDTA
|
| CO2 Concentration | 5 % |
| Medium |
Essential 8™ Flex
|
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes |
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | Yes |
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes |
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
Morphology pictures
Differentiation Potency
Microbiology / Virus Screening |
|
| Mycoplasma | Negative |
Certificate of Analysis |
|
| Is there a certificate of analysis available? |
Yes
Passage:
32
|
Genotyping
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
No
|
Other Genotyping (Cell Line) |
|
Genetic Modification
| Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.